| 摘要 |
This invention relates to novel polymorphic/pseudopolymorphic forms of 5-[4-[2-(5-ethyl-2-pyridyl)benzyl]thiazolidine-2,4-dione hydrochloride having formula (I). The invention also relates to a pharmaceutical composition comprising the novel polymorphic forms or its mixture and a pharmacuetically acceptable carrier. The polymorphic forms of th epresent invention ar emore active, as an antidiabetic than the hitherto known 5-[4-[2-(5-ethyl-2-pyridyl)ethoxyl]benzyl]thiazolidene-2,4-dione hydrochloride. |
